NEW YORK (AP) -- Scientific instrument makers Invitrogen Corp. and Applied Biosystems Inc. will take the name Life Technologies Corp. after their tie-up is complete, the companies said Wednesday.
The companies also announced new details of their corporate structure. Three current Applied Biosystems board members will be on the Life Technologies board: George Adam, Arnold Levine, and William Longfield. They will be joined by the nine members of Invitrogen's board.
The stock will trade on the Nasdaq Stock Market under the ticker "LIFE." When Invitrogen agreed to buy Applied Biosystems in June for $6.4 billion in cash and stock, the companies had said they would operate under the Applied Biosystems name. U.S. regulators have signed off on the deal, but the companies are waiting for European approval.
Life Technologies will continue selling instruments and products under the Applied Biosystems brand, and reagents under the Invitrogen name.
In morning trading, Invitrogen shares rose $1.28, or 4.5 percent, to $29.61, and Applied Biosystems stock edged up 31 cents to $31.17.
